Many bacteria acquire dissemination and virulence traits in G1-phase. CtrA, an 12 essential and conserved cell cycle transcriptional regulator identified in the dimorphic 13 alpha-proteobacterium Caulobacter crescentus, first activates promoters in late S-14 phase and then mysteriously switches to different target promoters in G1-phase. We 15 uncovered a highly conserved determinant in the DNA-binding domain (DBD) of CtrA 16 uncoupling this promoter switch. We also show that it reprograms CtrA occupancy in 17 stationary cells inducing a (p)ppGpp alarmone signal perceived by the RNA 18 polymerase beta subunit. A simple side chain modification in a critical residue within 19 the core DBD imposes opposing developmental phenotypes and transcriptional 20 activities of CtrA. A naturally occurring polymorphism in the rickettsial DBD resembles 21 a mutation that drives CtrA towards activation of the dispersal (G1-phase) program in 22
Introduction 27
Tight regulation of gene expression during the cell cycle is paramount to ensure 28
proper timing and coordination of DNA replication, chromosome segregation and cell 29 division, often concurrently with morphological changes. Caulobacter crescentus is a 30 phase transition that morphologically manifests with the differentiation from SW to ST 48 cells. Pili and the flagellum are lost from the same cell pole, followed by the onset of 49 stalk outgrowth from the vacated site 4 . Concurrently, the capsule is synthesized which 50 increases the cellular buoyancy 5 , and DNA synthesis initiates bidirectionally from a 51 single origin of replication (Cori, Figure 1A ) on the circular chromosome. A 52 multicomponent genetic circuit of global transcriptional activators and repressors 53 temporally and spatially coordinates these events at the molecular level 1 . 54
The late S-phase and G1-phase programs are both activated by CtrA, a highly 55 conserved member of the OmpR family of DNA-binding response regulators 1,2 . CtrA is 56 essential for viability and proper cell cycle control in C. crescentus 6 and in many other 57 alpha-proteobacteria 1 . CtrA switches from activating the late S-phase promoters 58 before cell division to inducing G1-phase promoters in the nascent SW cell chamber 59 at cytokinesis. While CtrA also binds Cori and prevents the initiation of DNA replication 60 in G1-phase 6-8 , it is degraded by the ClpXP protease during the G1àS transition 9 . It 61 is re-synthesized in late S-phase and again degraded in the ST compartment during 62 cytokinesis, while being maintained in the SW compartment ( Figure 1A) . The 63 conserved target motif (CtrA box: 5'-TTAA-N7-TTAA-3') is present in both promoter 64 investigated. 114
Here we unearth a molecular determinant within the DBD of CtrA that is required 115 to execute the switch from late S-to G1-phase promoters and to reprogram CtrA in 116 stationary C. crescentus cells accumulating (p)ppGpp. A highly conserved triad 117 centered in the core DBD dictates whether CtrA can switch G1-phase promoters and 118 use it to control the cell cycle during a growth phase transition induced by (p)ppGpp in 119 response to starvation stress. CtrA activity can be maintained in cells expressing a 120 mutant form of RNA polymerase that is blind to (p)ppGpp, indicating that transcriptional 121 regulation coordinates growth phase transition regulated by CtrA. 
Growth conditions 126
Caulobacter crescentus NA1000 and derivatives were grown at 30°C in PYE (peptone 127 yeast extract). Antibiotic concentrations used for C. crescentus include kanamycin 128 (solid: 20 μg/ml; liquid: 5 μg/ml), tetracycline (1 μg/ml), gentamycin (1 μg/ml) and 129 nalidixic acid (20 μg/ml). When needed, D-xylose or sucrose was added at 0.3% final 130
Spontaneous mutations that suppress the motility defect of the ctrA401 mutant cells 143 appeared as "flares" that emanated from nonmotile colonies after approximately 4 to 5 144 days of incubation at 30°C. Ten isolates (MS 1 to 10) were selected and tested for the 145 excision of the MGE by PCR using primers amplifying the CCNA_00477 (presence of 146 the MGE) and attB (MGE excised) fragments. Two ctrA401 MS (MS 2 and 4) were 147 subjected to whole genome sequencing. The Nextera kit from illumina was used for 148 library preparation with 50 ng of DNA as input. The Library molarity and quality was 149 assessed with the Qubit and Tapestation using a DNA High sensitivity chip (Agilent 150 Technologies). Libraries were loaded on a HiSeq 4000 single-read Illumina flow cell. 151
Reads of 50 bases were generated. The nine other suppressors were then sequenced 152 by Sanger sequencing for the CCNA_03998 (amplified using primers 3998_NdeI and 153 3998_EcoRI). The table 1 below summarizes the mutations obtained in the 154 suppressors. To confirm that these mutations were responsible for the suppression of 155 the motility defect of the ctrA401 mutant cells, ΔMGE ctrA401 and Δ3998 ctrA401 156 double mutants were constructed through ϕCr30 mediated generalized transduction of 157 the ctrA401 allele. The transducing phage stock is a lysate of ctrA401 MS2 158 ctrA401::pNPTS138-ctrA-ds. Sucrose 3% was then used to eliminate the pNPTS138 159 by homologous recombination and clones were screen for kanamycin susceptibility. 
Motility suppressors of NA1000 ΔptsP ΔspoT mutant cells 167
Spontaneous mutations that suppress the motility defect of the ΔptsP ΔspoT mutant 168 cell appeared as "flares" that emanated from nonmotile colonies after approximately 4 169 to 5 days of incubation at 30°C. One isolate (UG5591) was subjected to whole genome 170 sequencing, and mutation in the rpoB (rpoB H559Y ) gene was found. In the suppressor, 171 the histidine codon at position 559 in rpoB was changed to one encoding tyrosine 172 (change of nt 549505 from C to T relative to the NA1000 genome sequence). To 173 confirm that this mutation was responsible for improving the motility defect of the ΔptsP 174
ΔspoT mutant cells, we backcross the mutation rpoB H559Y into WT cells. To this end, a 175 pNPTS138-rpoC-ds, conferring kanamycin resistance, was integrated by homologous 176 recombination downstream of the rpoC gene in the ΔptsP ΔspoT rpoB H559Y mutant. 177
Next, ϕCr30 mediated generalized transduction was used to transfer the rpoB H559Y 178 allele into the WT cells. Sucrose 3% was then used to eliminate the pNPTS138-rpoC-179 ds by homologous recombination and clones were screen for kanamycin susceptibility. 180
Sanger sequencing was used to verify the integrity of the mutation using primers rpoB-181 seq1 and rpoB-seq2. 
Viability test on plates 317
Viability of WT, ctrA401 and derivatives was assessed with 4 µL drops of serial 318 dilutions of liquid culture (10 -1 to 10 -6 ), adjusted to OD660nm=1, on PYE plates, then 319 incubated for 2 days at 30°C or 37°C. 320
321
Chromatin ImmunoPrecipitation coupled to deep Sequencing (ChIP-Seq) 322
Mid-log phase and stationary phase cells cultured in PYE were cross-linked in 10mM 323 sodium phosphate (pH 7.6) and 1% formaldehyde at room temperature for 10 min and 324 on ice for 30 min thereafter and washed three times in phosphate-buffered saline 325 (PBS). Cells were lysed in a Ready-Lyse lysozyme solution (Epicentre Technologies) 326 according to manufacturer's instructions and lysates were sonicated in an ice-water 327 bath for 15 cycles 30 s ON and 30 s OFF, to shear DNA fragments to an average 328 length of 0.3-0.5 kbp and cleared by centrifugation at 14000 g for 2 min at 4°C. Lysates 329 were normalized by protein content, diluted to 1 ml using ChIP buffer (0.01% SDS, 330
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl plus 331 protease inhibitors (Roche, Switzerland) and pre-cleared with 80 μL of protein-A (rabbit 332 antibodies) agarose (Roche) and 100 μg BSA. Ten percent of the supernatant was 333 removed and used as total chromatin input DNA as described before 26 . 334
Two microliters of rabbit polyclonal antibodies to CtrA (Ardissone) were added to the 335 remains of the supernatant, incubated overnight at 4 °C with 80 μL of protein-A beads 336 pre-saturated with BSA, washed once with low salt buffer (0.1% SDS, 1% Triton X-337 100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1) and 150 mM NaCl), high salt buffer (0.1% 338 SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1) and 500 mM NaCl) and 339
LiCl buffer (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA and 10 mM 340
Tris-HCl (pH 8.1)), and twice with TE buffer (10 mM Tris-HCl (pH 8.1) and 1 mM 341 EDTA). The protein DNA complexes were eluted in 500 μL freshly prepared elution 342 buffer (1% SDS and 0.1 M NaHCO3), supplemented with NaCl to a final concentration 343 of 300 mM and incubated overnight at 65 °C to reverse the crosslinks. The samples 344 were treated with 2 μg of Proteinase K for 2 h at 45 °C in 40 mM EDTA and 40 mM 345
Tris-HCl (pH 6.5). DNA was extracted using phenol:chloroform:isoamyl alcohol 346 SeqMonk: the genome was subdivided into 50 bp probes, and for every probe we 360 calculated a value that represents a normalized read number per million (Supplemental 361 tables S2, S3 and S4). 362
Using the web-based analysis platform Galaxy (https://usegalaxy.org), CtrA ChIP-Seq 363 peaks were called using MACS2 28 relative to the total input DNA samples. The q-value 364 (false discovery rate, FDR) cut-off for called peaks was 0.05. Peaks were rank-ordered 365 according to fold-enrichment (Suppl . Table S5 ) and peaks with a fold-enrichment 366 values >2 were retained for further analysis. 367
The heatmaps in Figure S1 were generated using SeqMonk and ChIP-seq signals 
Results

384
CtrA401 uncouples the switch from late-S-phase to G1-phase promoters 385
We confirmed that the CtrA-activated promoter PfliQ is upregulated in ctrA401 386 cells at 30°C 6 using a PfliQ-lacZ promoter probe plasmid in which PfliQ is transcriptionally 387 fused to the promoterless lacZ gene. We observed a more than two-fold increase in 388
LacZ activity in ctrA401 cells (241%, Table 2) versus WT cells growing exponentially 389 at 30°C. To determine if other CtrA-activated promoters are upregulated in the same 390 manner, we conducted LacZ-based promoter probe assays in WT and ctrA401 cells at 391 30°C (Table 2) . Remarkably, we observed a similar behavior with promoters that CtrA 392 activates in late S-phase (e.g. PfliX, PfliL, PpleA, PcpaB and PCCNA_03790; Table 2 ), but not 393 with promoters that CtrA activates in G1-phase (e.g. PpilA, PflaF, PhfsJ, PCCNA_02061 or PsciP; 394 Table 2 ). In fact, promoters of the G1 class were poorly active in the ctrA401 395 background and immunoblotting revealed that proteins expressed from G1 phase 396 promoters that depend directly (HfsJ, PilA, SciP; Figure 1B , S1B, S1D and S2B) or 397 indirectly (SpmX; Figure 1B ) on CtrA are not (or poorly) expressed in ctrA401 cells. 398
These results suggest that ctrA401 cells are unable to activate these G1-phase 399 promoters, but efficiently induce the late S-phase promoter class. 400
To probe for commensurate changes in promoter occupancy of CtrA401 401 (T170I) versus WT CtrA, we conducted chromatin-immunoprecipitation followed by 402 deep-sequencing (ChIP-Seq; Figure 1C , S1A) analyses of CtrA-bound sites. 403
Immunoprecipitations were done by incubating polyclonal antibodies to CtrA with 404 chromatin extracted from WT and ctrA401 cells (grown exponentially at 30°C). Deep-405 sequencing revealed that the chromosomal occupancy of CtrA401 (T170I) is generally 406 elevated compared to that of CtrA (WT), without noticeably affecting CtrA abundance 407 inside cells ( Figure 1C , inset). Thus, the T170I mutation does not compromise general 408 binding to the CtrA box in vivo. As expected, the specific association of CtrA401 with 409 late S-phase promoters such as PfliQ, PcpaB and PfliF is increased compared to that of 410 CtrA (WT; Figure 1D ), while at G1-phase promoters, such as PsciP, PhvyA, PhfsJ, PtacA 411 and PpilA ( Figure 1D ), CtrA occupancy is clearly diminished. Moreover, a control 412 promoter that CtrA does not directly target (the promoter of the fljL flagellin gene) 413
showed poor occupancy of CtrA in vivo and little or no difference between WT and 414 ctrA401 cells ( Figure 1D , note change in scale). 415
We conclude that CtrA401 is impaired in the switch from late-S-phase to G1 416 phase promoter activation and binding. Since this defect also results in a failure to 417 express the negative regulator of late S-phase promoters 12,15,16 , SciP ( Figure 4D , 4E, 418 S1C, S1D), these promoters are no longer shut off and firing is maintained, resulting 419 in elevated activity. Thus, the negative regulation of CtrA on late S-phase target 420 promoters such as PfliQ is indirect, stemming from a defect in activating SciP 421 expression in ctrA401 cells which explains why this allele of ctrA surfaced in the 422 previous selection for loss of negative regulation at PfliQ 6 . Importantly, and contrary to 423 earlier interpretations of the phenotype of ctrA401 cells, our findings suggest that the 424 phenotypes observed at the permissive temperature are not due to a general loss of 425
CtrA function/binding at target promoters, but is instead due to a specific defect due to 426 crippled G1-phase promoter firing and the resulting overactivation of late S-phase 427 promoters. 428 429
Capsule inhibits swarming motility of ctrA401 cells 430
Since the G1-phase is the principal phase of motility in C. crescentus, motility 431 assays serve as proxy for perturbations in G1-phase duration (and gene expression). 432
Consistent with the defect in G1-phase promoter activation by the ctrA401 mutation, 433 these cells are poorly motile on swarm (0.3%) agar plates ( Figure 2B ) even though 434 early flagellar promoter fire at an elevated level (Table 2; Figure 2A ). Moreover, 435
immunoblotting revealed that the FljK flagellin, a late flagellar component that is 436 assembled into the flagellar filament, is also more abundant in ctrA401 cells than in 437 WT cells ( Figure 2B , S2A). Since a block in flagellar assembly prevents expression of 438 FljK 31 , these immunoblotting experiments indicate that ctrA401 cells do not suffer from 439 a flagellar assembly block and, thus, that swarming motility is impaired in ctrA401 cells 440
for (an)other reason(s). 441
To determine the basis of this motility defect, we isolated 10 motile suppressors 442 This sedimentation phenotype resembles that of capsule-less mutants that have a 451 reduced cellular buoyancy 5 . Indeed, buoyancy analyses by Percoll density gradient 452 centrifugation revealed that ctrA401-MS2 cultures only contained "heavy" cells ( Figure  453 2D), whereas ctrA401 cells were only "light". As WT cultures contain both "heavy" (non-454 capsulated) G1-phase cells and "light" (capsulated) S-phase cells ( Figure 2D ), we 455 reasoned that ctrA401 cells remain "light" because of a failure to activate a G1-phase 456 promoter and that this block also perturbs swarming motility. 457
The CtrA-activated promoter of the hvyA gene, encoding a G1-specific 458 capsulation inhibitor, fires in G1-phase (PhvyA) 12 . Loss of HvyA leads to constitutive 459 capsulation and thus only "light" cells in the culture 5 . After confirming that a 460 transcriptional fusion to the PhvyA-lacZ and a PhvyA-hvyA::lacZ translational fusion is 461 poorly active in ctrA401 cells ( Figure 2E ), we reasoned that the constitutive capsulation 462 phenotype of ctrA401 cells is due to a failure in expressing HvyA. Indeed, constitutive 463 expression of an epitope-tagged version of HvyA bearing a C-terminal Tandem Affinity 464
Purification (TAP) from a vanillate-inducible promoter on the pBBR-based plasmid 465 pMT335 32 not only reversed the buoyancy defect of ctrA401 cells ( Figure 2F ), but also 466 improved swarming motility. 467
If ctrA401 cells are always capsulated and "light", then the "heavy" ctrA401 MS 468 cells should lack capsule. Since capsule protects cells from infection by ϕCr30 by 469 masking its receptor, the S-layer protein RsaA 33 , we predicted that ctrA401 cells should 470 be resistant to infection by ϕCr30, whereas ctrA401-MS2 should be hypersensitive to 471 ϕCr30. The phage spot (lysis) tests shown in Figure 2D confirmed this prediction. As 472 control for specificity we also conducted phage spot tests with caulophage ϕCbK which 473 requires pili for infection 34 . Both ctrA401 and ctrA401-MS2 mutants are resistant to 474 ϕCbK because they do not express the pilA pilin gene encoding the structural subunit 475 of the pilus filament that is expressed from the CtrA activated PpilA promoter in G1-476 phase (Table 2, Figure S1B, S2B). By contrast, WT cells are piliated and thus infected 477 Why might the ctrA401-MS mutants have lost the ability to form capsule? We 479 suspected the acquisition of a mutation in a capsule biosynthesis gene in these 480 mutants. A cluster of capsule biosynthetic proteins is encoded on a mobile genetic 481 element (MGE; Figure S3B ) cells that can sporadically excise 5,35 . PCR-based analyses 482 of the ctrA401-MS mutants revealed that the MGE had been lost from ctrA401-MS4-7 483 cells as indicated by the increased abundance of the attB PCR product that is amplified 484 when the attB junction is created by MGE excision (Figure S3B, S3C ), whereas the 485 MGE is present in WT (NA1000) and ctrA401 cells. Further analysis by PCR revealed 486 that ctrA401-MS4-7 cells lacked the capsule genes (CCNA_03998) and the 487 CCNA_00477 encoded on the MGE. In the remaining mutants, CCNA_0477 encoded 488 on the MGE is present, but CCNA_03998 was not detected in ctrA401-MS2 and a 489 larger rearrangement of the CCNA_03998 had occurred in ctrA401-MS1 ( Figure S3C) . 490
Prompted by the observation that CCNA_03998 is rearranged or absent in the 491 aforementioned ctrA401-MS mutants, we asked if the remaining four MS mutants 492 (MS3, 8, 9, 10) had acquired point mutations in CCNA_03998 that would impair 493 function. Indeed, PCR-sequencing revealed that ctrA401-MS3 has a nonsense 494 mutation at codon 61 (changing the tryptophan codon to a stop codon), while ctrA401-495 MS8 and ctrA401-MS9 have an identical mutation at codon 331, changing a cysteine 496 codon into a stop codon. The remaining mutant, ctrA401-MS10, has a missense 497 mutation at codon 32, changing the proline codon to a histidine codon ( Figure S3D ). 498
Taken together these analyses suggest that loss of the MGE and, specifically, 499 loss of capsule biosynthetic function of the CCNA_03998 WbuB-like 500 glycosyltransferase, promotes swarming motility of ctrA401 cells. In support of the 501 conclusion that constitutive capsulation interferes with swarming motility and likely 502 flagellar function in ctrA401 cells, we transduced the ctrA401 mutation into ΔMGE cells 503 as well as ΔCCNA_03998 mutant cells and found that swarming motility is indeed 504 improved in the resulting double mutants compared to the ctrA401 parent ( Figure S3E ). 505
However, motility is reduced in these ΔMGE; ctrA401 mutants compared to ctrA401-506 MS mutants, presumably because of yet unknown mechanism of motility inhibition in 507 ctrA401 or because of unknown contributions conferred by the suppressor mutations 508 on the MGE. 509 510
Intragenic suppressor mutations of ctrA401 alter DNA-binding 511
To investigate the G1-promoter block of ctrA401 cells further, we designed 512 another suppressor screen to select for ameliorated G1-phase gene expression using 513 the pilA::PpilA-nptII transcriptional reporter conferring resistance to kanamycin 12,36 . For 514 practical reasons, we chose ctrA401-MS2 as host for the reporter since this mutant 515 showed the same regulatory defects on CtrA-dependent gene expression as ctrA401 516 parent cells (Table 2) , with the added benefit of enabling convenient transfer of the 517 pilA::PpilA-nptII reporter using ϕCr30-mediated generalized transduction, which is not 518 possible for ctrA401 parental cells (see above). The pilA::PpilA-nptII reporter confers 519 resistance to 40 μg/mL kanamycin (on plates) to WT cells ( Figure S4A ). As expected, 520 pilA::PpilA-nptII is poorly active in ctrA401-MS2 cells, precluding growth on kanamycin 521 (40 μg/mL) plates ( Figure S4A ). In an attempt to identify extragenic suppressor 522 mutations that restore G1-phase promoter activity to ctrA401 cells, we conducted 523 transposon (Tn) mutagenesis of the reporter strain using a himar1 Tn conferring 524 resistance to gentamicin. Selecting for resistance to gentamicin and kanamycin of 525 ctrA401-MS2 pilA::PpilA-nptII reporter cells following Tn mutagenesis, revealed several 526 clones with Tn insertions at different positions within or near the pilA promoter ( Figure  527 S4B, S4C, Table S6 ), suggesting that outward transcription form the Tn bypasses the 528 dependency for CtrA to activate PpilA-nptII. 529
As mapping of over 20 different Tn mutants failed to reveal Tn insertions in loci 530 other than PpilA, we sought intragenic suppressor mutations in ctrA401 that allow 531 growth of ctrA401-MS2 pilA::PpilA-nptII reporter cells on plates containing kanamycin 532 (40 μg/mL). To eliminate isolating mutants harboring promoter-up mutations in PpilA 533 that permit growth on kanamycin plates but that do not otherwise impact the CtrA 534 regulon, we imposed a second visual screen for stalks in the kanamycin-resistant 535 mutants, since the polar stalk is absent from ctrA401 cells 6 and it can be conveniently 536 recognized by differential interference contrast (DIC) microscopy. As shown in Figure  537 3A, ctrA401 and ctrA401-MS2 pilA::PpilA-nptII parental cells are stalkless when grown 538 in PYE, but stalks are produced in the ctrA401-SS (stalked suppressor) mutant. 539
Moreover, DIC microscopy and fluorescence-activated cell sorting (FACS) revealed 540 that the cell filamentation defect is also ameliorated in the SS mutant cells compared 541 to ctrA401 and ctrA401-MS2 pilA::PpilA-nptII parental cells ( Figure 3A) . 542
Backcrossing experiments and DNA sequencing revealed that the ctrA401-SS 543 mutant had acquired an additional mutation in ctrA, changing the threonine codon 168 544 into an isoleucine codon (T168I). T168I lies two residues ahead of the T170I mutation 545 in CtrA401 ( Figure 3B ) within the DNA-binding domain of CtrA. The stretch from 167-546 191 in C. crescentus CtrA is highly conserved in the alpha-proteobacteria ( Figure 3B) , 547 but strikingly T168 is also substituted by a hydrophobic residue (valine) at the 548 corresponding position in the rickettsial lineage (Ehrlichia canis in Figure 3B) , 549
suggesting that this position in CtrA likely reflects a key residue in determining the 550 DNA-binding activity of CtrA at G1-phase promoters in free-living alpha-proteobacteria 551 and developmental (growth phase transition) control in the obligate intracellular 552
lineage. 553
Modelling the promoter bound structure of WT and mutant CtrA ( Figure 3C) , 554 along with ChIP-Seq analysis of ctrA401-SS cells (obtained from backcrossing the 555 ctrA401-SS allele into WT cells, Figure 1C ) supported the key role of this residue. The 556
CtrA401-SS (T168I/T170I) protein shows an increase in occupancy at G1-phase 557 promoters and a reduction at late S-phase promoters, thus correcting the properties of 558 the CtrA401 (T170I) mutant towards the WT properties ( Figure 1C, 1D) . Importantly, 559
promoter probe assays confirmed that promoter firing was also ameliorated in the 560 ctrA401-SS mutant compared to ctrA401 cells: while firing is G1-phase elevated 561 compared to the ctrA401 parent (Table 2) , expectedly late S-phase promoters are 562 down-regulated since PsciP activity is also elevated ctrA401-SS compared ctrA401 563 cells. Immunoblotting confirmed that the steady-state levels of HfsJ and SpmX both 564 directly (HfsJ) or indirectly (SpmX) dependent on G1-phase promoters activated by 565
CtrA, are restored to near WT levels in ctrA401-SS cells compared to ctrA401 cells 566 ( Figure 1B) . 567
In addition to stalk formation, the other misregulated phenotypes of ctrA401 cells 568 are also ameliorated by the ctrA401-SS mutation, including the resistance to ϕCbK (i.e. 569 piliation, Figure 2D , S1B), as well as the resistance to ϕCr30 along with the exclusive 570 "light" buoyancy (i.e. constitutive capsulation, Figure 2D ) phenotype. As expected, 571 since the ctrA401-SS mutation allows the formation of non-capsulated G1 cells 572 because of the improved expression of HvyA, motility is also improved compared to 573 ctrA401 parental cells ( Figure 3D ). Importantly, ctrA401-SS cells have an elevated heat 574 tolerance (plating efficiency at 37°C) compared to ctrA401 cells ( Figure S1C ). 575
Thus, residues T170 and T168 define the G1 promoter binding capacity of CtrA 576 at G1-phase promoters and confer opposing phenotypes depending on the side chain 577 replacement. This notion is further reinforced by the previously finding of suppressor 578 mutations in these residues (i.e. T168A and T170A) with the opposite effect, restoring 579 motility to cells in which G1-promoters are deprepressed 12 . Determining the 580 transposon (Tn) insertions profile by Tn-Seq (transposon insertion sequencing) 581 analysis of ctrA401 (T170I) and ctrA (T170A) cells indeed proved the opposite 582 phenotypes ( Figure 3E, S5) . For example, for the divK gene that negatively regulates 583
CtrA activity and induces a G1 arrest when disrupted 11 , Tn insertions are 15-fold more 584 frequent in ctrA401 (T170I) cells versus ctrA (T170A) cells ( Figure 3E , Supplementary  585   Table S7 ). 586 587
CtrA reprogramming in stationary phase is mediated by RpoB via (p)ppGpp 588
The fact that CtrA is implicated in the rickettsial growth phase (developmental) 589 transition 18 along with the role of reside T168 described above, prompted us to 590 investigate the CtrA in stationary C. crescentus cells. We observed that the late S-591 phase promoter probe reporters PpleA-lacZ and PfliQ-lacZ are substantially upregulated 592 in stationary phase compared to exponential phase ctrA401 cells or compared to 593 stationary WT cells ( Figure 4A ). The stationary phase promoter induction of these two 594 promoters by CtrA401 and (WT) CtrA is enhanced by (p)ppGpp, the alarmone that is 595 produced by SpoT in stationary phase 37 as indicated by the fact the promoter activity 596 is attenuated in ΔspoT cells. This finding prompted us to define the CtrA stationary 597 phase target regulon by ChIP-Seq analysis in WT cells. We observed the ChIP-Seq 598 profiles of CtrA to change substantially between exponential and stationary phase cells 599 ( Figure 4B, 4C) . Moreover, robust CtrA occupancy on stationary phase chromatin 600
shows that the presence of SpoT enhances chromatin occupancy of CtrA in stationary 601 phase ( Figure 4B ) and that the activity of these CtrA-target promoters is indeed 602 induced in stationary phase in a manner that depends on SpoT compared to 603 exponential phase cells ( Figure S6 ). 604
As further confirmation for the role of (p)ppGpp in enhancing CtrA promoter 605 occupancy in stationary phase, ChIP-Seq also revealed that CtrA was also less 606 abundant on chromatin isolated from stationary cells lacking PtsP, the E1 component 607 of an alternate phosphoenolpyruvate transfer system that activates the SpoT pathway 608 upon nitrogen starvation 38 ( Figure 4B) . A prominent example of a stationary-phase 609 induced CtrA-target promoter is the G1-phase promoter of the hfsJ gene (PhfsJ, see 610
ChIP-Seq traces in Figure 4C ). The strong SpoT-dependent increase in CtrA 611 occupancy correlates well with the increase in HfsJ protein steady-state levels in 612 stationary phase by immunoblotting ( Figure 1B) . CtrA steady-state levels in stationary 613 phase cells are reduced in the absence of SpoT ( Figure 5A , right), suggesting that 614 occupancy of CtrA is enhanced by (p)ppGpp because it promotes an increase in CtrA 615
abundance. 616
Interestingly, FACS analysis revealed a pronounced cell cycle defect of ctrA401 617 cells in stationary phase compared to exponential phase or compared to stationary WT 618 cells ( Figure 5B ). In fact, ctrA401 cells accumulate extra chromosomes and there are 619 few S-phase cells compared to WT populations. The accumulation of extra 620 chromosomes in stationary ctrA401 cells is mitigated by the ΔspoT mutation and the 621 elevated (late S-phase) promoter activity in ctrA401 cells is curbed when SpoT is 622 inactivated (Table 2, Figure 4A ). To test whether this contribution of SpoT/(p)ppGpp is 623 mediated via allosteric control of RNA polymerase by (p)ppGpp, we sought suppressor 624 mutations that render cells independent of (p)ppGpp for cell cycle control. To this end, 625
we spotted ΔspoT ΔptsP double mutant cells on swarm agar and isolated spontaneous 626 suppressor mutants that overcome the swarming defect of the parent. Genome that the rpoB* mutation impacts the distribution of CtrA on its targets in vivo. Several 638 promoters that CtrA prominently binds to in WT exponential phase are further 639 increased in rpoB* cells as confirmed by the ChIP-Seq traces presented in Figure 5D . 640
The transcripts of CCNA_03890 and CCNA_03426, the former encoding a 641 hypothetical protein conserved in the Caulobacterales order and the latter a MarR-like 642 transcription factor, are strongly cell-cycle regulated like other CtrA-regulated 643 transcripts 40 , consistent with notion that their promoters are directly activated by CtrA 644 and enhanced in the presence of (p)ppGpp. In exponential phase cells, the rpoB* 645 mutation does not fully recapitulate the CtrA occupancy profile of stationary stationary 646 phase WT cells ( Figure 4B, 5C, 5D ), indicating that unknown determinants other than 647 to G1-phase 37,41-43 . Upon studying the C. crescentus ctrA401 mutant we discovered a 662 determinant uncoupling the two promoter classes activation by CtrA. Importantly, we 663 observed that binding of CtrA401 at late S-phase promoters is not compromised in 664 vivo. Instead, it is elevated compared to WT with a commensurate increase in promoter 665 activity, while G1-phase promoters show the inverse behavior. 666
In C. crescentus, the promoter switch drives cell surface structure remodeling, 667
including pili and capsule that are known virulence determinants in bacterial 668 pathogens 1 . The acquisition of pili in G1 cells is triggered by expression of the PilA 669 pilin 44 , while capsule is lost from G1 cells upon expression of the negative regulator of 670 capsulation, the HvyA transglutaminase homolog 5 . These traits collectively promote 671 the susceptibility of G1 cells to the bacteriophages ϕCr30 and ϕCbK that bind the S-672 layer and pili, respectively 33,34 . The ctrA401 mutant is resistant to both phages because 673 constitutive capsulation protects against infection by ϕCr30 5 , while loss of piliation is 674 due to the defect in PilA expression in ctrA401 cells and prevents infection by ϕCbK. 675
Since cellular dispersal functions are activated by the CtrA dependent promoter switch, 676 double stranded DNA phages such as ϕCr30 and ϕCbK may harness the opportunity 677 of infecting G1 cells in order to introduce their genomes into the host before 678 chromosome replication commences. Expression of HvyA not only reverses the 679 constitutive capsulation phenotype of ctrA401 cells, but also ameliorates the swarming 680 motility defect, indicating that capsule interferes with flagellar motility, explaining why 681
HvyA expression has been incorporated into the regulatory program of Caulobacter 682 G1 cells and orthologs appear to underlie similar control. Thus, such coordination is 683 likely critical for efficient dissemination and virulence properties of G1 cells in different 684 alpha-proteobacteria. 685
686
The pivotal role of residues T168 and T170 in CtrA 687
CtrA is essential and its predicted essentiality formed the basis for the isolation 688 of a lethal "loss of function" (ctrA401) mutation that was isolated at the restrictive 689 temperature of 37°C, while the second selection criterion was impaired negative 690 regulation of class II flagellar (late S-phase) activated by CtrA 6 , despite the known role 691 of CtrA being activating most target promoters 2 . How the negative and positive 692 regulation by CtrA on the same class of promoters could be instated was an unresolved 693 question. The results described here provide a rational explanation for this effect, as 694
we showed that only activation of the G1-promoter class is curbed by the CtrA 695 mutation. In principle, the T170I mutation in CtrA401 can also be viewed as a "gain of 696 function" mutation endowing CtrA401 with an extended ChIP profile ( Figure 1C ), most 697 likely reinforced by the reduction of sciP expression ( Figure 1C, 1D ; Figure S1C , S1D) 698 at 30°C. 699
By contrast, activating function of CtrA (or stability) is lost at 37°C and thus cells 700 suffer from insufficiency of essential cell division (and likely other) transcripts and/or 701 de-regulation of DNA replication, ultimately causing cell death. Since the mutation in 702 CtrA401 (T170I) lies in a highly conserved residue within the DNA-binding region, our 703 findings unearth a critical residue directing promoter, gene expression and thus 704 deterministic phenotypic switches. Molecular modelling suggests that the residues 705 T170 and T168 do not engage in direct contacts with DNA, however they likely fulfill a 706 critical role in proper positioning of the recognition helices or cooperative effects 707 required for promoter binding and activation. It is possible that a small quantitative 708 difference in affinity for the target box, especially in the context of architecture of G1 709 promoters, underlies or contributes to the qualitative block in the promoter switch of 710 the CtrA401 mutant versus WT CtrA. 711
Our suppressors analyses revealed a compensatory mutation (T168I) in close 712 proximity to the T170I mutation near the highly conserved DNA-binding region of CtrA 713 ( Figure 3B ). This mutation not only partially reinstates the promoter switch to CtrA401 714 (Table 2) stationary phase and such reprogramming may reflect an ancestral role of CtrA that is 754 still exploited by the obligate intracellular rickettsial pathogens to direct the growth 755 phase transition of Ehrlichia chaffeensis from reticulate cells into dense-cored cells 18 . 756
While E. chaffeensis does not offer a powerful genetic system to dissect how growth-757 phase dependent reprogramming of CtrA occurs, we show that in C. crescentus 758 alarmone-based nutritional signals acting through RNAP play an important role. 759
Having shown previously that PctrA activity is increased in a (p)ppGpp dependent 760 manner 46 , we confirmed that CtrA levels are decreased in stationary ΔspoT cells and 761 that a mutation in RpoB (H559Y) bypasses the need for (p)ppGpp. This mutation also 762 augments the steady-levels of CtrA, consistent with the previous evidence that 763 Table 2 . Activity of CtrA-activated promoters in C. crescentus WT & mutants. Promoter-probe assays of transcriptional reporters carrying a various lacZ-based CtrA dependent promoter in WT and ctrA401 cells and derivatives. Black refers to late Sphase promoters and blue to the G1-phase promoters. spmX is represented in purple as it is not a direct target of CtrA. Values are expressed as percentages (activity in WT set at 100%). Data from four independent experiments, error bars are standard deviation. ND, Not determined. Table 1 . WT !"#$%&' 
